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HIV-1 variants in breast milk and peripheral blood have been compared in three HIV-1 infected mothers. Analysis of DNA
and RNA env C2-V3 sequences showed a differential distribution of HIV variants between the two compartments. The major
provirus variant found in breast milk corresponds to a minor variant in the blood of two mothers. In the third mother, the
predominant proviral variant detected in breast milk was not represented in the HIV-1 blood population. The major RNA
variant in breast milk was not represented in the blood of two mothers. The predominant RNA variant in breast milk and blood
was however the same for the third mother. Unexpectedly, the pattern of free virus variants in breast milk of three mothers
did not correspond to that of the proviral form, suggesting that free viruses do not derive from infected cells in breast milk.
The observation of a compartmentalization of HIV-1 between peripheral blood and breast milk emphasizes that postnatal
transmission of HIV occurs with variants that may not be predicted from the analysis of circulating viral populations. © 2002INTRODUCTION
Sexual transmission of human immunodeficiency virus
(HIV-1) and transmission of HIV from mother to child
during breastfeeding occur at mucosal surfaces. Breast
milk of HIV-1-seropositive women contains both free
HIV-1 particles and cell-associated HIV in the form of
infected mononuclear cells. In contrast to cervicovaginal
secretions where virus is known to originate from local
production of HIV in the genital compartment (Ellerbrock
et al., 2001), the origin of free and of cell-associated virus
in breast milk remains unclear. The finding that the pre-
dominant HIV variants found in cervicovaginal secretions
are minor variants in peripheral blood based on se-
quences of the env gene, or exhibit different genotypic
resistance mutations, strongly support the concept of a
compartmentalization of viral variants between blood
and the genital mucosa (Overbaugh et al., 1996; Si-
Mohamed et al., 2000). The finding of a positive correla-
tion between levels of HIV RNA in plasma of infected
mothers and the risk of transmission of HIV suggested
that HIV is primarily produced in the systemic compart-
ment before passage into breast milk (Semba et al., 1999;
The European Collaborative Study, 1999). It may be, how-
ever, that HIV is also produced locally in infected muco-
1 To whom correspondence and reprint requests should be ad-
dressed at Unite´ INSERM U430, Hoˆpital Broussais, 96, rue Didot109sal macrophages, lymphocytes, and/or epithelial cells.
Thus, ductal and alveolar cells of human mammary ep-
ithelium were shown to be susceptible to HIV-1 infection
in vitro (Toniolo et al., 1995). We have previously shown
that the epitopic repertoire of anti-gp 160 IgG and secre-
tory IgA in breast milk differs from that of serum, sug-
gesting a compartmentalization of the humoral response
against HIV-1 between blood and breast milk (Becquart
et al., 1999). In the present study, we have compared
amino acid sequences in the V3 loop of viral clones
generated from plasma and breast milk of three African
HIV-infected mothers (Nos. 25, 35, and 65). The results
indicate that free virus and provirus differ between pe-
ripheral blood and breast milk.
RESULTS
Viral load in plasma and breast milk
The levels of HIV RNA in breast milk of mother no. 25
and no. 35 were 22,500 and 1,200 copies/ml, respectively.
The low amount of available breast milk of mother no. 65
did not allow the quantitation of viral load. The distribu-
tion of viral RNA between the acellular nonlipidic and the
lipidic fraction of breast milk of mother 25 was 84 and
16%, respectively. A similar distribution was found in the
breast milk of mother 35 with 70% of the viral RNA
present in the acellular nonlipidic fraction and 30% in the
lipid fraction. The plasma levels of HIV RNA in mothersElsevier Science (USA)
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ficient to allow for PCR amplification, cloning, and se-
quencing.
Characterization of DNA and RNA variants in
peripheral blood
We obtained at least 14 viral clones from peripheral
blood cells and from free virus in plasma of each mother.
We then compared the C2–V3 env sequences of DNA
and RNA HIV-1 viral populations in peripheral blood (Fig.
1). In mother 35 and mother 65, the variants were found
to be heterogeneous with a range of 0 to 20% of nucle-
otide sequence differences between clones. A compa-
rable level of variability in V3 sequence was reported in
blood of HIV-1-infected mothers (Wolinsky et al., 1992). In
mother 35, DNA provirus was however mixed in the
population of viral RNA variants (Fig. 2). In mother 65, the
two populations were clearly different and the two qua-
sispecies of DNA clones were separated from the RNA
clones upon phylogenetic analysis with significant boot-
strap values (99 and 100%). The comparison of HIV-1
variants within the DNA and RNA populations in mothers
35 and 65 showed a more uniform virus population with
regard to DNA sequences. In the third mother (mother
25), the populations of RNA and DNA virus in blood were
homogeneous, with less than 5% nucleotide sequence
difference between the more divergent clones. Thus,
there is no significant clustering of the sequences within
this population (all bootstrap values below 60%) (Fig. 2).
Characterization of DNA and RNA variants in breast
milk
The populations of DNA as well as of RNA variants
detected in breast milk were highly homogeneous (Fig.
2). DNA clones derived from breast milk were distinct
FIG. 1. Deduced amino acid sequences of DNA and RNA HIV variants present in breast milk and blood of mother nos. 25, 35, and 65. Consensus
sequences of the V3 loop corresponding to macrophagic tropism (Cons Mac) and T cell tropism (Cons T Cell) as defined by Chesebro et al. (1992),
are indicated at the bottom of the figure. Positions 21 and 25 are indicated by an asterisk on the top of the sequence. Basic amino acids of the V3
loop in Cons T Cell are underlined. The charge of the V3 loop amino acids and the tropism of the variants are indicated at the end of each sequence.
The frequencies of clones with identical amino acids sequences are indicated at the beginning of each sequence. Each dot indicates identity with
the reference sequence.
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from those of RNA in the breast milk in the case of
mothers 35 and 25. In the case of mother 65, DNA and
RNA variants were clearly seeded by one quasispecies
(Fig. 2).
Comparison of DNA and RNA variants between
breast milk and peripheral blood
The minor DNA virus variant detected in peripheral
blood of mothers 25 and 35 (m1  1/15 and m3  1/13,
respectively) was found to be predominant in breast milk
(M1  14/15 and M3  1/15, respectively) (Fig. 3). In
contrast, the major RNA variant in plasma (M2  11/16)
was also found to be the major variant in breast milk
(M2  8/16) in the case of mother 25. The major RNA
virus variant in breast milk was not found in the viral
population in the plasma of mother 35 (Fig. 3). In mother
65, none of the RNA and DNA major variants present in
breast milk were recovered among identified variants in
peripheral blood.
Prediction of X4- and R5-viral tropism of HIV variants
in peripheral blood and breast milk
The X4- and R5-tropism of viruses in peripheral blood
and breast milk were predicted based on the analysis of
the deduced amino acid sequences of gp120–V3 hyper-
variable regions. DNA and RNA variants in blood and
breast milk of mothers 25 and 35 were R5-tropic (Fig. 1).
In contrast, 50% of the population of DNA variants in
peripheral blood of mother 65 was R5-tropic and 50%
was X4-tropic (Fig. 1). No X4-tropic HIV-1 variants were
detected among RNA variants in plasma of mother 65
(Fig. 1). In breast milk, HIV variants were R5-tropic in the
case of all three mothers.
FIG. 1—Continued
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HIV-1 clade determination
The analysis of env sequences showed that viruses
derived from mothers 25 and 65 were of subtype A and
G, respectively (Fig. 4A). The env sequences data of
mother 35 did not allow us to determine the clade.
Subsequent phylogenetic analysis of env sequences of
HIV of mother 35 (Fig. 4B) showed that the C2–V3 virus
sequences were similar to that previously reported for
mother CAM-1710 in Yaounde (Roques et al., 1999). This
env sequence corresponds to a cluster named env k
belonging to the B and D HIV-1 M subtypes.
DISCUSSION
In the present study, we demonstrate a compartmen-
talization of HIV-1 between breast milk and blood of
infected mothers. Extensive genetic characterization of
RNA and DNA variants amplified from breast milk and
blood of three infected mothers revealed distinct pat-
terns of distribution of viral populations. Thus, in the case
of two mothers, a minor DNA virus variant in peripheral
blood was found to be predominant in the breast milk. In
the third mother, none of the major DNA virus variants
present in the breast milk was recovered among variants
in peripheral blood.
Macrophages and lymphocytes in breast milk either
originate from blood or migrate from mucosal inductive
sites of mucosal-associated lymphoid tissue to the glan-
dular epithelium in the breast tissue. Our observations in
mothers 25 and 35 favor the hypothesis that infection of
breast milk cells occurred with a selected set of variants
of HIV-1 that migrated from the blood compartment to the
mammary gland. In contrast, in the case of mother 65,
the proviral variant found in breast milk could originate
from local mucosal viral replication. It is possible that
infected cells in the mammary gland constitute a latent
HIV-1 reservoir that becomes replicative during preg-
nancy and thus contributes to the HIV-1 viral load in
breast milk.
Our data are the first demonstration of a differential
FIG. 1—Continued
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distribution of proviral variants between blood and breast
milk. A compartmentalization of HIV has previously been
described for the genital compartment, i.e., semen and
cervicovaginal secretions (Delwart et al., 1998; Eller-
brock et al., 2001; Overbaugh et al., 1996; Zhu et al.,
1996). Compartmentalization of virus between blood and
the mucosa probably results in a different pattern in the
secretory antibody response to env epitopes in breast
milk compared to serum (Becquart et al., 2000).
Analysis of RNA variants present in mothers 35 and 65
indicated the variants to be distinct between blood and
breast milk. The major RNA variant present in breast milk
was not even represented among the viral population in
plasma. In the case of mother 25, however, the distribu-
tion of variants in the breast milk was close to that
observed in plasma. Free virus in the breast milk either
originates from the systemic compartment or from local
replication of HIV at mucosal sites within infected mac-
rophages and lymphocytes. The observation that DNA
and RNA viral populations differ in the breast milk sug-
gest that free virus is not produced by infected cells in
the breast milk. This result is in agreement with previous
observations that most infected cells in milk are defec-
tive or latently infected with defective or transiently silent
viruses (Boulerice et al., 1990). Furthermore, lactoferrin
(Viani et al., 1999), or secretory leukocyte protein inhibitor
(SLPI) (McNeely et al., 1995), may inhibit viral replication
in milk in a nonspecific fashion. In the case of mother 25,
the source of free virus in the breast milk is likely to be
the systemic compartment. In the case of the major
variants in breast milk of mothers 35 and 65, another
source of free virus has to be considered, e.g., infected
cells that would have migrated from the intestinal mu-
cosa to reach the mammary submucosa.
Phylogenetic analysis of the V3-gp120 sequences in
blood and corresponding breast milk indicated that the
mothers were infected with three different subtypes of
viruses, commonly retrieved in central Africa. In contrast
to the viral populations detected in blood, RNA as well as
DNA populations in the breast milk were found to be
homogeneous. Viruses found in the breast milk and
blood of mothers 25 and 65 were of subtype A and G,
respectively. Phylogenetic analysis of env sequences of
mother 35 showed that the C2–V3 virus sequence be-
longs to a separate cluster belonging to the B and D
HIV-1 M subtypes.
We further determined the R5- and X4-tropism of vi-
ruses present in blood and breast milk by analyzing the
FIG. 2. Phylogenetic relationship of viral clones derived from blood and breast milk of mother nos. 25, 35, and 65. Neighbor-joining trees were
obtained from alignment of 204 nucleotides for the clones obtained from mothers 25, 35, and 65. The numbers near nodes indicate the percentage
of bootstrap replicates. Bootstrap values (% of 100 resampling) were computed using Seqboot, DNAdist, Neighbor, and Consense from the PHYLIP
3.5 package. Transition/transversion ratio was set to 1.7. Blood RNA (open square), blood DNA (open triangle), milk RNA (filled square), milk DNA (filled
triangle). The scale refers to the distance between sequences (i.e., the number of substitution per site).
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charge and the position of selected amino acids in the
gp120-V3 hypervariable region. All breast milk DNA and
RNA viruses that we analyzed corresponded to the pre-
dicted R5-tropic phenotype. This finding is consistent
with the preferential mucosal transmission of R5-tropic
HIV-1 (Zhu et al., 1996). In contrast to HIV-1 RNA, we
observed 50% of predicted R5- and 50% of predicted
X4-tropic among HIV-1 DNA variants in peripheral blood
of mother 65 who had been treated with AZT from the
36th week of pregnancy. The dichotomy between the
tropism of free virus and provirus may be the result of a
higher susceptibility to AZT of highly replicative X4-tropic
viruses.
The present demonstration of a compartmentalization
of HIV-1 populations between peripheral blood and
breast milk and, within the breast milk, between free
virus and provirus, emphasizes that postnatal transmis-
sion of HIV occurs with variants that may not be pre-
dicted from the analysis of circulating viral populations.
MATERIALS AND METHODS
Plasma and breast milk
Plasma and breast milk were obtained 3 weeks after
delivery from three HIV-seropositive mothers (25, 35, and
65) from Yaounde (Cameroon), in whom HIV infection had
been diagnosed during pregnancy. The three mothers
were asymptomatic (stage A of the WHO classification)
and gave an informed oral consent for participation in the
study. Mother 65 received AZT from the 36th week of
pregnancy. The two other mothers did not benefit from an
intervention with AZT since anti-retroviral treatment was
not available at that time in Yaounde. The breast milk
was centrifuged at 3000 rpm for 10 min at 4°C to obtain
the acellular and lipid fractions. The centrifugation pellet,
corresponding to the cellular fraction of breast milk, was
washed with 1 ml of PBS prior to storage at 80°C.
Freshly obtained venous blood was centrifuged at
4000 rpm for 15 min; the plasma was aliquoted and
frozen at 80°C. The cell pellet was washed with Tris
buffer (Tris–HCl 1 mM pH 7.4, NaCl 10 mM, and MgCl2 50
mM) to lyse red cells and stored at 80°C.
DNA and RNA preparation
DNA extraction was carried out using the Qiamp blood
and tissue kit (Qiagen AG, Basel, Switzerland) according
to the manufacturer’s recommendations. RNA extraction
was performed from both the acellular and the lipidic
fraction of breast milk using 1 ml of TRIzol (Life Technol-
ogies, Inc., Gaithersburg, MD). Preparation of plasma
RNA was carried out from 140 l by the Qiamp viral RNA
minikit (Qiagen). Two extractions of DNA and RNA were
performed for all samples. The extracted RNA was im-
mediately reverse transcribed into cDNA, using the
primer ED12 (Delwart et al., 1993). The reverse transcrip-
tion mixture (11.5 l) contained 20 U RNAsin (Gibco-BRL,
FIG. 3. Comparison of major and minor DNA and RNA viral variants found in breast milk and blood of mother nos. 25, 35, and 65.
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Gaithersburg, MD), 0.5 L primer ED12 50 M, and 5 L
RNA. The mixture was heated at 65°C for 10 min prior to
the addition of 5.5 L of a solution containing 4 L RT
buffer (Gibco-BRL), 1 L dithiothreitol 100 mM (Gibco-
BRL), 0.5 L dNTP 10 mM, and 0.25 L reverse transcrip-
tase superscript (Gibco-BRL). Reverse transcription was
performed for 1 h at 42°C.
Quantitation of HIV RNA
RNA was extracted from plasma and from the acellular
fraction and lipid layer of breast milk, as described
above. Quantification of cell-free virus was performed by
means of the NASBA assay (Durham, NC) following the
manufacturer’s instructions.
PCR
To increase the likelihood of detecting different viral
variants, products obtained from a minimum of two
nested PCRs were used for cloning. DNA and cDNA (1
g) samples were amplified by a two-step amplification
procedure. The first PCR was performed on 50 l of a
reaction mixture containing 5 L 10 PCR buffer, 1 L
dNTP 10 mM, 1 l of each out primer ED5 and ED12 50
M, 2.5 U taq polymerase (Perkin-Elmer, Cetus Norwalk,
FIG. 4. Determination of subtype origin of the virus in blood and breast milk of mother nos. 25, 35, and 65. (A) Phylogenetic relationship for each
of the newly derived viruses were determined in env (C2–V3 region) using four clones from blood and breast milk. Neighbor-joining (NJ) tree was
inferred from nucleotide sequence alignments with reference strains (see Materials and Methods for further details). Normalized name from the
reference strain are given according to the Los Alamos HIV data base. The numbers near nodes indicate the percentage of bootstrap replicates
supporting the clade (100 resampling). The scale indicates substitutions per site and refers to the horizontal branch lengths. The vertical branch
lengths are for clarity only. (B) Evidence of virus from mother no. 35 belonging to the nonclassified cluster env “k” (Roques et al., 1999).
Maximum-likelihood tree was computed from alignment of these sequences with the Los Alamos AIDS databases references alignment sequences
(http://hiv-web.lanl.gov). A, B, C, D, F, G, H, J, and K refer to the subtype of reference sequences, and CRF_01 to 06 refer to the circulating recombinant
form. The four sequences from mother no. 35 identified in Fig. 1: blood RNA (open square), blood DNA (open triangle), milk RNA (filled square), milk
DNA (filled triangle). CAM001, CAM1710, BCB88, 97-272, 97-517, and CMR6122VD, CMR370, CMR68.4 refer to sequences described belonging to clade
“k” (Roques et al., 1999; Takehisa et al., 1998). The numbers near nodes indicate the percentage of bootstrap replicates (100 resamplings) supporting
the subtype in NJ tree. The scale indicates substitutions per site.
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CT). The reactions were carried out at 94°C 1 min, 55°C
1 min, and 72°C 1 min for 40 cycles. Following the
first-round PCR, 5 l of the product was amplified for 40
cycles with the inner primers PV32 and PV33 (Zhu et al.,
1998) at 94°C 30 s, 52°C 30 s, and 72°C 1 min. Amplified
DNA products were analyzed by electrophoresis on a 2%
agarose gel.
Cloning
Cloning of nested PCR fragments was carried out twice
by means of the PCR-Script Amp cloning kit (Stratagene
Cloning Systems, CA) according to the manufacturer’s rec-
ommendations. Colonies were directly screened by PCR
using the inner primers PV32 and PV33.
Sequencing
PCR products of the expected size were sequenced
using an ABI3700 sequencer and the Abi Prism Big Dye
Terminator Cycle Sequencing Ready Reaction kit (PE
Biosystem, Foster City, CA).
Sequence analysis and tree alignment
A specific analysis was performed on sequences of
viral clones obtained from breast milk and blood of each
mother so as to compute the phylogenetic tree of all
C2–V3 sequences in both compartments. CLUSTALW 1.8
was used to align the inferred amino acid sequences
pooled from the HIV-1 gene databank (http://hiv-web.
lanl.gov/) and derived sequences from the plasma or breast
milk derived PCR clones (Thompson et al., 1994). The
resulting amino acid based alignment was used as an
exact guide for placing of indels in a nucleotide align-
ment. Gap-containing sites as well as sequences corre-
sponding to PCR primers were removed prior to analysis.
Phylogenetic trees were built using PHYLIP (Felsenstein,
1989) or PAUP* version 4b8 (Swofford, 1999). Distance-
matrix based trees were estimated with the neighbor-
joining method (Saitou and Nei, 1987) using the HKY85
model of nucleotide substitution (Hasegawa et al., 1985).
The reliability of the branching order was estimated by
performing 100 bootstrap replicates using the HKY85
model. Maximum-likelihood trees were also constructed
using the HKY85 model of nucleotide substitution incor-
porating an estimate of the transition/transversion ratio
and a shape parameter (using six discrete categories of
rate variation) for a gamma distribution of rate heteroge-
neity among sites, both estimated on the neighbor-join-
ing tree. The neighbor-joining tree topology was used as
the starting tree in a heuristic search using TBR branch
swapping to search for the maximum likelihood tree.
Prediction of X4 and R5 viral tropism
We have used deduced amino acid sequences of V3
region to predict the tropism of the virus (Chesebro et al.,
1992, 1997; Fouchier et al., 1992; Hoffman et al., 2002;
Hung et al., 1999; Long et al., 2000; Shioda et al., 1991,
1992; Westervelt et al., 1992). A variant was predicted to
be R5-tropic when the charge of the V3 loop was below
5 and exhibited a serine (S) or a glycine (G) in position 11
and an aspartatic acid (D), a glutamic acid (E), or an
alanine (A) in position 25. A variant was predicted to be
X4-tropic when the charge of the V3-loop was above 5
and exhibited a lysine (K) or an arginine (R) in position 11
or 25. When the charge of the V3-loop is equal to 5, we
determined the tropism of variant using the nature of
amino acid in position 11 and 25. Variants without cys-
teine on both sides of the V3-loop were considered to be
deficient.
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